Literature DB >> 24656402

Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients.

Manal Azzouz1, Janne Rømsing2, Henrik S Thomsen3.   

Abstract

OBJECTIVE: To study fluctuations in estimated glomerular filtration rate (eGFR) in relation to contrast medium (CM) enhanced magnetic resonance imaging (MRI) and computed tomography (CT) compared to control groups in outpatients.
MATERIALS AND METHODS: eGFR was determined right before the imaging procedure and three days later at the department or at the patient's home. The iodine-based and gadolinium-based contrast media were the same as used for all other examinations at the department.
RESULTS: A total of 716 patients completed the study. There was a statistically significant, but not clinically relevant rise in eGFR after three days in all four groups. The average eGFR variation was 4.8 ml/min/1.73 m(2). There were large variations in eGFR between the two measurements in 45.8% of the patients as they had a change greater than ± 10 ml/min/1.73 m(2). Only three patients fulfilled the contrast-induced nephropathy (CIN) requirement when the definition s-creatinine ≥ 44 μmol/l (0.5mg/dl) was used.
CONCLUSIONS: eGFR in outpatients undergoing MRI or CT did vary independently of whether the patient received contrast or not. The findings probably reflect the natural variations in s-creatinine levels. This should be taken into consideration when CIN is studied.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CIN; Fluctuations; Gadolinium-based contrast media; Iodine-based contrast media; Outpatients; eGFR

Mesh:

Substances:

Year:  2014        PMID: 24656402     DOI: 10.1016/j.ejrad.2014.02.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.

Authors:  Mark Corbett; Ana Duarte; Alexis Llewellyn; James Altunkaya; Melissa Harden; Martine Harris; Simon Walker; Stephen Palmer; Sofia Dias; Marta Soares
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

Review 2.  Update on the renal toxicity of iodinated contrast drugs used in clinical medicine.

Authors:  Michele Andreucci; Teresa Faga; Raffaele Serra; Giovambattista De Sarro; Ashour Michael
Journal:  Drug Healthc Patient Saf       Date:  2017-05-22

Review 3.  Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Aart J van der Molen; Peter Reimer; Ilona A Dekkers; Georg Bongartz; Marie-France Bellin; Michele Bertolotto; Olivier Clement; Gertraud Heinz-Peer; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

4.  Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease.

Authors:  Christian Kroneberger; Christian N Enzweiler; Andre Schmidt-Lucke; Ralph-Ingo Rückert; Ulf Teichgräber; Tobias Franiel
Journal:  Acta Radiol Open       Date:  2015-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.